Gregory L. Braden

4.0k total citations · 1 hit paper
91 papers, 2.5k citations indexed

About

Gregory L. Braden is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Gregory L. Braden has authored 91 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Nephrology, 27 papers in Pulmonary and Respiratory Medicine and 16 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Gregory L. Braden's work include Dialysis and Renal Disease Management (11 papers), Kidney Stones and Urolithiasis Treatments (8 papers) and Pharmacological Effects and Toxicity Studies (8 papers). Gregory L. Braden is often cited by papers focused on Dialysis and Renal Disease Management (11 papers), Kidney Stones and Urolithiasis Treatments (8 papers) and Pharmacological Effects and Toxicity Studies (8 papers). Gregory L. Braden collaborates with scholars based in United States, Belgium and Poland. Gregory L. Braden's co-authors include Michael J. Germain, Jeffrey Mulhern, Michael H. O’Shea, Anthony E. Zimmermann, Alan H. Morris, Robert P. Hoffman, Jennifer J. Bedford, S Nash, Miguel A. Vazquez and Harold I. Feldman and has published in prestigious journals such as JAMA, Annals of Internal Medicine and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Gregory L. Braden

83 papers receiving 2.4k citations

Hit Papers

Effect of Clopidogrel on ... 2008 2026 2014 2020 2008 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory L. Braden United States 23 928 908 698 400 296 91 2.5k
Jeffrey S. Berns United States 36 2.0k 2.1× 774 0.9× 339 0.5× 481 1.2× 269 0.9× 139 4.2k
Kamal Sud Australia 26 1.3k 1.4× 340 0.4× 367 0.5× 377 0.9× 188 0.6× 143 2.6k
Chiu‐Ching Huang Taiwan 30 1.2k 1.3× 499 0.5× 384 0.6× 667 1.7× 277 0.9× 147 3.3k
Olivier Moranne France 29 1.7k 1.8× 504 0.6× 197 0.3× 309 0.8× 290 1.0× 143 3.0k
Colin Geddes United Kingdom 31 1.4k 1.5× 801 0.9× 227 0.3× 681 1.7× 388 1.3× 112 3.3k
Chi‐Bon Leung Hong Kong 29 1.8k 1.9× 314 0.3× 642 0.9× 459 1.1× 288 1.0× 69 2.5k
Domingo Hernández Spain 36 1.2k 1.3× 886 1.0× 270 0.4× 1.4k 3.6× 341 1.2× 221 4.6k
Norman Muirhead Canada 35 2.0k 2.2× 948 1.0× 322 0.5× 1.1k 2.7× 399 1.3× 91 4.7k
Chi Bon Leung Hong Kong 25 1.2k 1.3× 487 0.5× 466 0.7× 285 0.7× 141 0.5× 73 2.8k
Ladan Golestaneh United States 22 843 0.9× 280 0.3× 225 0.3× 282 0.7× 183 0.6× 79 2.1k

Countries citing papers authored by Gregory L. Braden

Since Specialization
Citations

This map shows the geographic impact of Gregory L. Braden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory L. Braden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory L. Braden more than expected).

Fields of papers citing papers by Gregory L. Braden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory L. Braden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory L. Braden. The network helps show where Gregory L. Braden may publish in the future.

Co-authorship network of co-authors of Gregory L. Braden

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory L. Braden. A scholar is included among the top collaborators of Gregory L. Braden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory L. Braden. Gregory L. Braden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Landry, Daniel L., et al.. (2025). Semaglutide reverses the chronic myopathy of hyperkalemic periodic paralysis: a case report. BMC Nephrology. 26(1). 179–179.
2.
Landry, Daniel L., et al.. (2023). Treatment of severe metformin-associated lactic acidosis with renal replacement therapy and tris-hydroxymethyl aminomethane: a case report. Journal of Medical Case Reports. 17(1). 462–462. 1 indexed citations
3.
Lam, Charles, Anna Siefkas, Nicole S. Zelin, et al.. (2021). Using Machine Learning as a Precision Medicine Approach for Remdesivir and Corticosteroids as COVID-19 Pharmacotherapies. Clinical Therapeutics. 1 indexed citations
5.
Verma, Ashish, et al.. (2021). <b><i>Brevundimonas vesicularis</i></b> Peritonitis in a Chronic Peritoneal Dialysis Patient. Case Reports in Nephrology and Dialysis. 11(3). 314–320. 2 indexed citations
6.
Crisi, Giovanna M., et al.. (2020). Hypocomplementemic Urticarial Vasculitis: Interstitial Nephritis with New Microtubular Deposits and Successful Response to Rituximab. Journal of the American Society of Nephrology. 31(10S). 580–581.
7.
Braden, Gregory L., Arlene B. Chapman, David H. Ellison, et al.. (2020). Advancing Nephrology. Clinical Journal of the American Society of Nephrology. 16(2). 319–327. 7 indexed citations
8.
Allen, Angier, Samson Mataraso, Anna Siefkas, et al.. (2020). A Racially Unbiased, Machine Learning Approach to Prediction of Mortality: Algorithm Development Study. JMIR Public Health and Surveillance. 6(4). e22400–e22400. 35 indexed citations
9.
Landry, Daniel L., et al.. (2018). Oxcarbazepine Therapy for Complete Central Diabetes Insipidus. Case Reports in Nephrology and Dialysis. 8(1). 20–24. 4 indexed citations
10.
Lewis, Eli C., et al.. (2012). Metabolic and Neuroendocrine Responses to Roux-en-Y Gastric Bypass. I: Energy Balance, Metabolic Changes, and Fat Loss. The Journal of Clinical Endocrinology & Metabolism. 97(8). E1440–E1450. 22 indexed citations
11.
Freda, Benjamin J., Mara Slawsky, Jaya Mallidi, & Gregory L. Braden. (2011). Decongestive Treatment of Acute Decompensated Heart Failure: Cardiorenal Implications of Ultrafiltration and Diuretics. American Journal of Kidney Diseases. 58(6). 1005–1017. 18 indexed citations
12.
Braden, Gregory L., et al.. (2007). Preliminary Observations of Urinary Calcium and Osteopontin Excretion in Premature Infants, Term Infants and Adults. Neonatology. 93(4). 241–245. 5 indexed citations
13.
Kimmel, Paul L., et al.. (2004). The role of circulating immune complexes and biocompatibility of staphylococcal protein A immunoadsorption in mitomycin C-induced hemolytic uremic syndrome. American Journal of Kidney Diseases. 44(4). e50–e58. 1 indexed citations
14.
Khoo, Michelle S.C., Gregory L. Braden, David W. Deaton, et al.. (2003). Outcome and complications of intraoperative hemodialysis during cardiopulmonary bypass with potassium-rich cardioplegia. American Journal of Kidney Diseases. 41(6). 1247–1256. 11 indexed citations
15.
Lipkowitz, George S., Robert L. Madden, Jeffrey Mulhern, et al.. (1999). Long-term maintenance of therapeutic cyclosporine levels leads to optimal graft survival without evidence of chronic nephrotoxicity. Transplant International. 12(3). 202–207. 12 indexed citations
16.
Braden, Gregory L., et al.. (1997). Ritodrine- and terbutaline-induced hypokalemia in preterm labor: Mechanisms and consequences. Kidney International. 51(6). 1867–1875. 34 indexed citations
17.
Braden, Gregory L., et al.. (1997). Effect of Diuretics on Urinary Oxalate, Calcium, and Sodium Excretion in Very Low Birth Weight Infants. PEDIATRICS. 99(6). 814–818. 34 indexed citations
19.
Braden, Gregory L., et al.. (1989). Urinary Oxalate Excretion by Very Low Birth Weight Infants Receiving Parenteral Nutrition. PEDIATRICS. 84(5). 860–863. 29 indexed citations
20.
Braden, Gregory L., et al.. (1986). Hemoperfusion for Treatment of N-Acetylprocainamide Intoxication. Annals of Internal Medicine. 105(1). 64–65. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026